From the market update three weeks ago:
This year we have significantly invested in various business development initiatives, in particular to open up export markets, and it is our view that these initiatives continue to be a vital component needed for the commercialisation of our new products, particularly in our target US and NZ markets, to provide returns for the medium to long term. We continue to have success in the task of obtaining the required USA State approvals for the HV2TM Barrier, having now achieved approvals in five States. We are progressively winning support from established industry partners and we are getting closer to formal sales and marketing agreements for the HV2TM Barrier and the Omni-StopTM Bollard range.
And today:
... The Company has secured its first order of its new HV2TM temporary barrier system to a major equipment hire company in New Zealand, for delivery in July. Commenting on the order, CEO Mr. Darren Hotchkin said, “This initial sale of a new product is a critical milestone for us in introducing the first free-standing TL-4 MASH tested temporary barrier system in the world. This is the start of the commercialisation stage of this new product, which is progressing well with regulatory approvals in five US states and also, more recently, the province of Ontario in Canada.”
All systems go for Saferoads. The company is generating profits (and has done so for each of the last three years) and appears to be in the early stages of a substantial growth phase, having built a strong platform for such growth over the last 5 years.
- Forums
- ASX - By Stock
- SRH
- Ann: Saferoads secures first HV2 Barrier order
Ann: Saferoads secures first HV2 Barrier order, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRH (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.791M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
SRH (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online